Jiangsu Kanion Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Kanion Pharmaceutical Co., Ltd. with three other
companies in this sector in CHINA :
Beijing Aosaikang Pharmaceutical Co Ltd
sales of 4.52 billion Chinese Renmimbi [US$674.81 million]
of which 100%
was Pharmaceutical manufacturing),
Renhe Pharmacy Company Limited
(4.58 billion Chinese Renmimbi [US$684.11 million]
of which 99%
was Medicine), and
Tong Ren Tang Technologies Company Limited
(4.48 billion Chinese Renmimbi [US$668.51 million]
of which 63%
was The Company).
During the year ended December of 2019, sales at
Jiangsu Kanion Pharmaceutical Co., Ltd. were 4.57 billion Chinese Renmimbi (US$681.86 million).
increase of 19.4%
versus 2018, when the company's sales were 3.82 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jiangsu Kanion Pharmaceutical Co., Ltd.
(and since 2014, sales have increased a total of 78%).
Sales of Other Operations saw an increase
that was more than double the company's growth rate: sales were up
149.9% in 2019, from
9.74 million Chinese Renmimbi to 24.35 million Chinese Renmimbi.